(Q36810352)

16 August 2017

1 reference

title

Nasopharyngeal carcinoma: molecular pathogenesis and therapeutic developments (English)

1 reference

16 August 2017

Qian Tao

1

1 reference

PubMed ID

17477889

16 August 2017

Anthony T C Chan

series ordinal

2

1 reference

16 August 2017

4 May 2007

1 reference

Expert Reviews in Molecular Medicine

16 August 2017

1 reference

16 August 2017

9

1 reference

16 August 2017

1-24

1 reference

16 August 2017

12

1 reference

Induction of malignant nasal cavity tumours in Wistar rats fed Chinese salted fish

16 August 2017

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

Induction of c-Met proto-oncogene by Epstein-Barr virus latent membrane protein-1 and the correlation with cervical lymph node metastasis of nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

Plasma Epstein-Barr virus DNA and residual disease after radiotherapy for undifferentiated nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

The Detection of thec-mycandrasOncogenes in Nasopharyngeal Carcinoma by Immunohistochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

Identification of virus-encoded microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

Epstein-Barr virus microRNAs are evolutionarily conserved and differentially expressed

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

An infrequent point mutation of the p53 gene in human nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

THY1 is a candidate tumour suppressor gene with decreased expression in metastatic nasopharyngeal carcinoma.

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

Definition of three minimal deleted regions by comprehensive allelotyping and mutational screening of FHIT,p16(INK4A), and p19(ARF) genes in nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

Epigenetic inactivation of CHFR in nasopharyngeal carcinoma through promoter methylation

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

Analysis of genetic alterations in primary nasopharyngeal carcinoma by comparative genomic hybridization

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

Quantitative plasma hypermethylated DNA markers of undifferentiated nasopharyngeal carcinoma.

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

c-erbB-2 gene amplification in nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

Epidermal growth factor receptor in undifferentiated carcinoma of the nasopharynx

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

MDM2 expression in EBV-infected nasopharyngeal carcinoma cells

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

Prognostic significance of tumor angiogenesis, Ki 67, p53 oncoprotein, epidermal growth factor receptor and HER2 receptor protein expression in undifferentiated nasopharyngeal carcinoma--a prospective study.

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

Dual regulation of the DeltaNp63 transcriptional activity by DeltaNp63 in human nasopharyngeal carcinoma cell

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

Significance of c-Myc and Bcl-2 protein expression in nasopharyngeal carcinoma.

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

Analysis of bcl-2 expression in normal, inflamed, dysplastic nasopharyngeal epithelia, and nasopharyngeal carcinoma: association with p53 expression

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

Bcl-2 proto-oncogene expression in Epstein-Barr-virus-associated nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

A20 RNA expression is associated with undifferentiated nasopharyngeal carcinoma and poorly differentiated head and neck squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

https://api.crossref.org/works/10.1017%2FS1462399407000312

1 reference

7 January 2021

The genetic approach to the Epstein-Barr virus: from basic virology to gene therapy

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

Epstein-Barr virus-driven gene therapy for EBV-related lymphomas

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

Preferential response of cancer cells to zebularine.

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

ras mutations are uncommon in nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

Induction of Epstein-Barr virus kinases to sensitize tumor cells to nucleoside analogues

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

Dual stimulation of Epstein-Barr Virus (EBV)-specific CD4+- and CD8+-T-cell responses by a chimeric antigen construct: potential therapeutic vaccine for EBV-positive nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

The association of E-cadherin expression and the methylation status of the E-cadherin gene in nasopharyngeal carcinoma cells.

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

Treatment of nasopharyngeal carcinoma with Epstein-Barr virus--specific T lymphocytes

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

Regulation of the H19 imprinting gene expression in human nasopharyngeal carcinoma by methylation

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

Cell therapy of stage IV nasopharyngeal carcinoma with autologous Epstein-Barr virus-targeted cytotoxic T lymphocytes.

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

Azacitidine induces demethylation of the Epstein-Barr virus genome in tumors.

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

Adoptive transfer of allogeneic Epstein-Barr virus (EBV)-specific cytotoxic T cells with in vitro antitumor activity boosts LMP2-specific immune response in a patient with EBV-related nasopharyngeal carcinoma.

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

Adoptive transfer of autologous Epstein-Barr virus-specific cytotoxic T cells for nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

Multicenter, phase II study of cetuximab in combination with carboplatin in patients with recurrent or metastatic nasopharyngeal carcinoma.

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

BRD7, a novel bromodomain gene, inhibits G1-S progression by transcriptionally regulating some important molecules involved in ras/MEK/ERK and Rb/E2F pathways

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

Transcription of BamHI-A region of the EBV genome in NPC tissues and B cells.

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

Epstein-Barr virus is localized in the tumour cells of nasal lymphomas of NK, T or B cell type.

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

Epstein-Barr virus expression within keratinizing nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

The expression of p63 is associated with the differential stage in nasopharyngeal carcinoma and EBV infection

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

A phase III study of adjuvant chemotherapy in advanced nasopharyngeal carcinoma patients

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

Nasal NK- and T-cell lymphomas share the same type of Epstein-Barr virus latency as nasopharyngeal carcinoma and Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

Nasopharyngeal carcinoma cell line (C666-1) consistently harbouring Epstein-Barr virus

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

Identification of differentially expressed genes in nasopharyngeal carcinoma by means of the Atlas human cancer cDNA expression array.

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

Analysis of Epstein-Barr virus infection in nasopharyngeal biopsies from a group at high risk of nasopharyngeal carcinoma.

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

High-resolution analysis of genomic copy number alterations in bladder cancer by microarray-based comparative genomic hybridization

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

Promoter hypermethylation of the EDNRB gene in nasopharyngeal carcinoma.

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

Epstein-Barr-virus-infected nasopharyngeal intraepithelial lymphocytes

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

Adjuvant chemotherapy with vincristine, cyclophosphamide, and doxorubicin after radiotherapy in local-regional nasopharyngeal cancer: results of a 4-year multicenter randomized study

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

Occupational risk factors for nasopharyngeal cancer among female textile workers in Shanghai, China

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

Nasopharyngeal carcinoma in Malaysian Chinese: occupational exposures to particles, formaldehyde and heat

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

Linkage of a nasopharyngeal carcinoma susceptibility locus to the HLA regions

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

Adulthood consumption of preserved and nonpreserved vegetables and the risk of nasopharyngeal carcinoma: a systematic review

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

Role of N-nitroso compounds (NOC) and N-nitrosation in etiology of gastric, esophageal, nasopharyngeal and bladder cancer and contribution to cancer of known exposures to NOC.

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

A susceptibility locus at chromosome 3p21 linked to familial nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

Focus on nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

Stealth technology: how Epstein-Barr virus utilizes DNA methylation to cloak itself from immune detection.

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

Lessons from hereditary colorectal cancer

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

The tumor suppressor Wnt inhibitory factor 1 is frequently methylated in nasopharyngeal and esophageal carcinomas.

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

Epstein-Barr virus as a therapeutic target in Hodgkin's disease and nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union against cancer stage III and IV nasopharyngeal cancer of the endemic varie

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

Nasopharyngeal intraepithelial lesion: latent Epstein-Barr virus infection with malignant potential

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

Evidence for lytic infection by Epstein-Barr virus in mucosal lymphocytes instead of nasopharyngeal epithelial cells in normal individuals.

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: The Hong Kong experience

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

Genome-wide scan for familial nasopharyngeal carcinoma reveals evidence of linkage to chromosome 4

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

Trends in incidence and mortality of nasopharyngeal carcinoma over a 20-25 year period (1978/1983-2002) in Sihui and Cangwu counties in southern China

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

Infrequent MDM2 gene amplification and absence of gross WAF1 gene alterations in nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

Epidemiology of nasopharyngeal carcinoma.

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

Familial risk and clustering of nasopharyngeal carcinoma in Guangdong, China

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

The National Cancer Data Base report on the relationship of race and national origin to the histology of nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

Association of HLA class I and II alleles and extended haplotypes with nasopharyngeal carcinoma in Taiwan

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

Alterations of BLU, a candidate tumor suppressor gene on chromosome 3p21.3, in human nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

Expression of the Epstein-Barr virus (EBV)-encoded latent membrane protein 2A (LMP2A) in EBV-associated nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

Association between high initial tissue levels of cyclin d1 and recurrence of nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

Activation and adoptive transfer of Epstein-Barr virus-specific cytotoxic T cells in solid organ transplant patients with posttransplant lymphoproliferative disease.

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

Id-1-induced Raf/MEK pathway activation is essential for its protective role against taxol-induced apoptosis in nasopharyngeal carcinoma cells

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

DNA methylation and the Epstein-Barr virus

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

Epstein-Barr virus: 40 years on

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

Nasopharyngeal carcinoma in situ (NPCIS)--pathologic and clinical perspectives

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

Epstein-Barr virus in the pathogenesis of NPC.

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

Epstein-Barr virus (EBV) and its associated human cancers--genetics, epigenetics, pathobiology and novel therapeutics.

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

A conditionally replicating adenovirus for nasopharyngeal carcinoma gene therapy.

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

Malignant transformation of Epstein-Barr virus-negative Akata cells by introduction of the BARF1 gene carried by Epstein-Barr virus

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

Nasopharyngeal brush biopsies and detection of nasopharyngeal cancer in a high-risk population

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

Nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

Loss of heterozygosity on the short arm of chromosome 3 in nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

Cytogenetics of undifferentiated nasopharyngeal carcinoma xenografts from southern Chinese

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

The association of squamous cell carcinomas of the nasopharynx with Epstein-Barr virus shows geographical variation reminiscent of Burkitt's lymphoma

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

Molecular cytogenetic characterization of nasopharyngeal carcinoma cell lines and xenografts by comparative genomic hybridization and spectral karyotyping

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

The stress-responsive gene GADD45G is a functional tumor suppressor, with its response to environmental stresses frequently disrupted epigenetically in multiple tumors.

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

Epigenetic disruption of two proapoptotic genes MAPK10/JNK3 and PTPN13/FAP-1 in multiple lymphomas and carcinomas through hypermethylation of a common bidirectional promoter.

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

Overall Survival After Concurrent Cisplatin-Radiotherapy Compared With Radiotherapy Alone in Locoregionally Advanced Nasopharyngeal Carcinoma

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

Construction of tree models for pathogenesis of nasopharyngeal carcinoma.

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

Chemotherapy in locally advanced nasopharyngeal carcinoma: an individual patient data meta-analysis of eight randomized trials and 1753 patients.

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

Conventional and array-based comparative genomic hybridization analysis of nasopharyngeal carcinomas from the Mediterranean area

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

The EORTC Early Clinical Trials Cooperative Group experience with 5-aza-2'-deoxycytidine (NSC 127716) in patients with colo-rectal, head and neck, renal carcinomas and malignant melanomas

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

Concurrent and adjuvant chemotherapy for nasopharyngeal carcinoma: a factorial study

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

Silencing of the retinoid response gene TIG1 by promoter hypermethylation in nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

Nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

Functional epigenetics identifies a protocadherin PCDH10 as a candidate tumor suppressor for nasopharyngeal, esophageal and multiple other carcinomas with frequent methylation

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

Systemic treatment strategies and therapeutic monitoring for advanced nasopharyngeal carcinoma.

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

Lung metastasis alone in nasopharyngeal carcinoma: A relatively favorable prognostic group

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

High level expression of deltaN-p63: a mechanism for the inactivation of p53 in undifferentiated nasopharyngeal carcinoma (NPC)?

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

Preliminary results of a randomized trial comparing neoadjuvant chemotherapy (cisplatin, epirubicin, bleomycin) plus radiotherapy vs. radiotherapy alone in stage IV(> or = N2, M0) undifferentiated nasopharyngeal carcinoma: a positive effect on progr

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

The candidate tumor suppressor gene BLU, located at the commonly deleted region 3p21.3, is an E2F-regulated, stress-responsive gene and inactivated by both epigenetic and genetic mechanisms in nasopharyngeal carcinoma.

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

Evaluation of hypermethylated tumor suppressor genes as tumor markers in mouth and throat rinsing fluid, nasopharyngeal swab and peripheral blood of nasopharygeal carcinoma patient

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

Frequent c-myc and Int-2 overrepresentations in nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

The major 8p22 tumor suppressor DLC1 is frequently silenced by methylation in both endemic and sporadic nasopharyngeal, esophageal, and cervical carcinomas, and inhibits tumor cell colony formation.

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

RASSF1A is a target tumor suppressor from 3p21.3 in nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

Fine mapping of the 11q22-23 tumor suppressive region and involvement of TSLC1 in nasopharyngeal carcinoma.

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

Familial nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

Epstein-barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

Changing epidemiology of nasopharyngeal carcinoma in Hong Kong over a 20-year period (1980-99): an encouraging reduction in both incidence and mortality

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

Epigenetic inactivation of the deleted in lung and esophageal cancer 1 gene in nasopharyngeal carcinoma.

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

Noninvasive diagnosis of nasopharyngeal carcinoma: nasopharyngeal brushings reveal high Epstein-Barr virus DNA load and carcinoma-specific viral BARF1 mRNA.

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

Epstein–Barr Virus in Burkitt's Lymphoma and Nasopharyngeal Carcinoma: EBV DNA in Biopsies of Burkitt Tumours and Anaplastic Carcinomas of the Nasopharynx

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

Array-based comparative genomic hybridization analysis identified cyclin D1 as a target oncogene at 11q13.3 in nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

Expression of the Epstein-Barr virus immediate early gene, BZLF1, in nasopharyngeal carcinoma tumor cells

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

A prospective randomized study of chemotherapy adjunctive to definitive radiotherapy in advanced nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

Results of a prospective randomized trial comparing neoadjuvant chemotherapy plus radiotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

Concurrent Chemotherapy-Radiotherapy Compared With Radiotherapy Alone in Locoregionally Advanced Nasopharyngeal Carcinoma: Progression-Free Survival Analysis of a Phase III Randomized Trial

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: positive effect on overall and progression-free survival

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

Detection of subclinical riasopharyngeal carcinoma by fibreoptic endoscopy and multiple biopsy

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

Preliminary results of a randomized study on therapeutic gain by concurrent chemotherapy for regionally-advanced nasopharyngeal carcinoma: NPC-9901 Trial by the Hong Kong Nasopharyngeal Cancer Study Group

1 reference

https://api.crossref.org/works/10.1017%2FS1462399407000312

7 January 2021

10.1017/S1462399407000312

Identifiers

DOI

0 references

PubMed ID

17477889

1 reference

PubMed ID

17477889